Abstract
Diabetic retinopathy (DR) is a common microvascular disorder which occurs in type 2 diabetes mellitus (T2DM) patients due to chronic hyperglycemia. Previous studies reported that serum zinc (Zn) and vitamin A levels were associated with certain diabetic microvascular complications. However, the relationship between Zn and vitamin A levels with the severity of DR in type 2 diabetic patients is not clear. We aimed to analyze the relationship between serum Zn and vitamin A levels with the severity of DR in T2DM. Sixty T2DM patients were selected from whom attending to the ophthalmology center of hospital from June 2017 and Feb 2018. Patients were categorized as controls, non-proliferative DR (NPDR), and proliferative DR (PDR). Anthropometric, dietary, and physical activity data were gathered. Fasting blood samples were taken to measure biochemical parameters. Serum Zn and vitamin A levels were measured via enzymatic-calorimetric and HPLC methods, respectively. Results showed that serum Zn and vitamin A levels were significantly lower in the PDR group than the controls (p = 0.03 and p = 0.008, respectively). Serum low-density lipoprotein (LDL.C) was significantly higher in the PDR than the control group (p = 0.02). Adjusting for the other variables, increase in serum Zn and vitamin A levels reduced risk of DR by 25.7% and 31.1%, respectively (p = 0.02 and p = 0.007). Higher serum LDL.C increased DR severity by 28.7%, adjusted for the variables (95% CI = 0.002, 0.02; p = 0.01). Lower serum Zn and vitamin A levels, as well as higher LDL.C in the T2DM patients, are related to DR severity.
Similar content being viewed by others
References
National estimates and general information on diabetes and prediabetes in the United States, Centers for Disease Control and Prevention, Atlanta, Ga, USA, 2011
Klein R, Klein BE, Moss SE et al (1998) The Wisconsin epidemiologic study of diabetic retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105(10):1801–1815
Maroufizadeh S, Almasi-Hashiani A, Hosseini M, Sepidarkish M, Omani Samani R (2017) Prevalence of diabetic retinopathy in Iran: a systematic review and meta-analysis. Int J Ophthalmol 10(5):782–789
Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376(9735):124–136
Powell SR (2000) The antioxidant properties of zinc. J Nutr 130:1447S–1454S
Zienab M, Anhar O, Gomaa M et al (2004) Association between retinol metabolism and diabetic retinopathy. Pol J Food Nutr Sci 13(4):391–396
Erikstrup C, Mortensen OH, Nielsen AR, Fischer CP, Plomgaard P, Petersen AM, Krogh-Madsen R, Lindegaard B, Erhardt JG, Ullum H, Benn CS, Pedersen BK (2009) RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes. Diabetes Obes Metab 11:204–212
Wang H, Chu W, Hemphill C, Hasstedt SJ, Elbein SC (2002) Mutation screening and association of human retinoid X receptor gamma variation with lipid levels in familial type 2 diabetes. Mol Genet Metab 76:14–22
Prasad AS (2008) Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol 43(5):370–377
Roussel AM, Kerkeni A, Zouari N, Mahjoub S, Matheau JM, Anderson RA (2003) Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr 22(4):316–321
Mousavi SN, Faghihi A, Motaghinejad M et al (2018) Zinc and selenium co-supplementation reduces some lipid peroxidation and angiogenesis markers in a rat model of NAFLD-fed high fat diet. Biol Trace Elem Res 181(2):288–295
Adachi Y, Yoshida J, Kodera Y, Kiss T, Jakusch T, Enyedy EA, Yoshikawa Y, Sakurai H (2006) Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes. Biochem Biophys Res Commun 351(1):165–170
Alscher DM, Braun N, Biegger D et al (2005) Induction of metallothionein in proximal tubular cells by zinc and its potential as an endogenous antioxidant. Kidney Blood Press Res 28(3):127–133
Ugarte M, Grime GW, Lord G, Geraki K, Collingwood JF, Finnegan ME, Farnfield H, Merchant M, Bailey MJ, Ward NI, Foster PJ, Bishop PN, Osborne NN (2012) Concentration of various trace elements in the rat retina and their distribution in different structures. Metallomics 4(12):1245–1254
Bok D (1985) Retinal photoreceptor-pigment epithelium interactions. Invest Ophthalmol Vis Sci 26(12):1659–1694
Booth ML, Ainsworth BE, Pratt MI et al (2003) International physical activity questionnaire: 12–country reliability and validity. Med Sci Sports Exerc 195(9131/03):1381–1395
Kowluru RA, Kennedy A (2001) Therapeutic potential of anti-oxidants and diabetic retinopathy. Expert Opin Investig Drugs 10(9):1665–1676
Moustafa SA (2004) Zinc might protect oxidative changes in the retina and pancreas at the early stage of diabetic rats. Toxicol Appl Pharmacol 201(2):149–155
Ansari NH, Zhang W, Fulep E et al (1998) Prevention of pericyte loss by trolox in diabetic rat retina. J Toxicol Environ Health A 54(6):467–475
Kowluru RA, Engerman RL, Case GL et al (2001) Retinal glutamate in diabetes and effect of antioxidants. Neurochem Int 38(5):385–390
Obrosova IG, Minchenko AG, Marinescu V et al (2001) Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia 44(9):1102–1110
Agardh CD, Agardh E, Hultberg B et al (1998) The glutathione levels are reduced in Goto-Kakizaki rat retina, but are not influenced by aminoguanidine treatment. Curr Eye Res 17(3):251–256
Kowluru RA, Engerman RL, Kern TS (2000) Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine. Curr Eye Res 21(4):814–819
Woollard ACS, Bascal ZA, Armstrong GR et al (1990) Abnormal redox status without increased lipid peroxidation in sugar cataract. Diabetes 39(11):1347–1352
Morrison SA, Russell RM, Carney EA et al (1978) Zinc deficiency: a cause of abnormal dark adaptation in cirrhotics. Am J Clin Nutr 31(2):276–281
Afridi HI, Kazi TG, Kazi N et al (2011) Evaluation of status of zinc, copper, and iron levels in biological samples of normal children and children with night blindness with age groups of 3–7 and 8–12 years. Biol Trace Elem Res 142:323–334
Mochizuki K, Murase H, Imose M, Kawakami H, Sawada A (2006) Improvement of scotopic electroretinograms and night blindness with recovery of serum zinc levels. Jpn J Ophthalmol 50(6):532–536
Luo Y, Zhao J, Han X et al (2015) Relationship between serum zinc level and microvascular complications in patients with type 2 diabetes. Chin Med J 128(24):3276–3282
Clermont AC, Aiello LP, Mori F et al (1997) Vascular endothelial growth factor and grade of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol 124(4):433–446
Wang X, Wang G, Wang Y (2009) Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy. Am J Ophthalmol 148(6):883–889
Adamis AP, Miller JW, Bernal MT et al (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118(4):445–450
Andreoli CM, Miller JW (2007) Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 18(6):502–508
Adachi T, Teramachi M, Yasuda H, Kamiya T, Hara H (2012) Contribution of p38 MAPK, NF-휅B and glucocorticoid signaling pathways to ER stress-induced increase in retinal endothelial permeability. Arch Biochem Biophys 520(1):30–35
Scheppke L, Aguilar E, Gariano RF, Jacobson R, Hood J, Doukas J, Cao J, Noronha G, Yee S, Weis S, Martin MB, Soll R, Cheresh DA, Friedlander M (2008) Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits. J Clin Invest 118(6):2337–2346
Kim J, Kim KM, Kim CS, Sohn E, Lee YM, Jo K, Kim JS (2012) Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidaserelated oxidative stress. Free Radic Biol Med 53(2):357–365
Acknowledgements
Authors are very thankful to all patients who participated in the present study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval was obtained from the Ethical Committee of Zanjan University of Medical Sciences, Zanjan, Iran. The present study has been performed in accordance with the ethical standards as laid down in the Declaration of Helsinki.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
rostamkhani, H., Mellati, A.A., Tabaei, B.S. et al. Association of Serum Zinc and Vitamin A Levels with Severity of Retinopathy in Type 2 Diabetic Patients: a Cross-Sectional Study. Biol Trace Elem Res 192, 123–128 (2019). https://doi.org/10.1007/s12011-019-01664-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-019-01664-z